vs
Arcutis Biotherapeutics, Inc.（ARQT）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
Arcutis Biotherapeutics, Inc.的季度营收约是REPUBLIC BANCORP INC的1.4倍（$129.5M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs 13.4%，领先10.8%），Arcutis Biotherapeutics, Inc.同比增速更快（81.5% vs 5.3%），过去两年Arcutis Biotherapeutics, Inc.的营收复合增速更高（61.6% vs -11.5%）
Arcutis Biotherapeutics是一家临床阶段生物制药企业，专注于开发和商业化免疫介导皮肤病领域的创新处方疗法，产品管线覆盖银屑病、特应性皮炎、斑秃等适应症，主要服务美国市场的患者及医疗服务提供者，填补皮肤科诊疗领域的未满足需求。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
ARQT vs RBCAA — 直观对比
营收规模更大
ARQT
是对方的1.4倍
$94.3M
营收增速更快
ARQT
高出76.2%
5.3%
净利率更高
RBCAA
高出10.8%
13.4%
两年增速更快
ARQT
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $129.5M | $94.3M |
| 净利润 | $17.4M | $22.8M |
| 毛利率 | 91.0% | — |
| 营业利润率 | 14.2% | 29.3% |
| 净利率 | 13.4% | 24.2% |
| 营收同比 | 81.5% | 5.3% |
| 净利润同比 | 261.2% | 20.0% |
| 每股收益（稀释后） | $0.14 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARQTRBCAA
| Q4 25 | $129.5M | $94.3M | ||
| Q3 25 | $99.2M | $93.5M | ||
| Q2 25 | $81.5M | $93.8M | ||
| Q1 25 | $65.8M | $135.8M | ||
| Q4 24 | $71.4M | $89.5M | ||
| Q3 24 | $44.8M | $88.1M | ||
| Q2 24 | $30.9M | $86.9M | ||
| Q1 24 | $49.6M | $120.3M |
净利润ARQTRBCAA
| Q4 25 | $17.4M | $22.8M | ||
| Q3 25 | $7.4M | $29.7M | ||
| Q2 25 | $-15.9M | $31.5M | ||
| Q1 25 | $-25.1M | $47.3M | ||
| Q4 24 | $-10.8M | $19.0M | ||
| Q3 24 | $-41.5M | $26.5M | ||
| Q2 24 | $-52.3M | $25.2M | ||
| Q1 24 | $-35.4M | $30.6M |
毛利率ARQTRBCAA
| Q4 25 | 91.0% | — | ||
| Q3 25 | 91.2% | — | ||
| Q2 25 | 90.8% | — | ||
| Q1 25 | 86.6% | — | ||
| Q4 24 | 90.3% | — | ||
| Q3 24 | 87.7% | — | ||
| Q2 24 | 88.8% | — | ||
| Q1 24 | 93.4% | — |
营业利润率ARQTRBCAA
| Q4 25 | 14.2% | 29.3% | ||
| Q3 25 | 8.6% | 40.4% | ||
| Q2 25 | -17.9% | 43.0% | ||
| Q1 25 | -37.3% | 44.1% | ||
| Q4 24 | -10.7% | 25.8% | ||
| Q3 24 | -87.3% | 38.4% | ||
| Q2 24 | -162.3% | 37.0% | ||
| Q1 24 | -63.8% | 32.2% |
净利率ARQTRBCAA
| Q4 25 | 13.4% | 24.2% | ||
| Q3 25 | 7.5% | 31.8% | ||
| Q2 25 | -19.5% | 33.5% | ||
| Q1 25 | -38.1% | 34.8% | ||
| Q4 24 | -15.1% | 21.2% | ||
| Q3 24 | -92.8% | 30.1% | ||
| Q2 24 | -169.6% | 29.0% | ||
| Q1 24 | -71.4% | 25.4% |
每股收益（稀释后）ARQTRBCAA
| Q4 25 | $0.14 | — | ||
| Q3 25 | $0.06 | — | ||
| Q2 25 | $-0.13 | — | ||
| Q1 25 | $-0.20 | — | ||
| Q4 24 | $-0.09 | — | ||
| Q3 24 | $-0.33 | — | ||
| Q2 24 | $-0.42 | — | ||
| Q1 24 | $-0.32 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.9M | $220.0M |
| 总债务越低越好 | $109.0M | — |
| 股东权益账面价值 | $189.5M | $1.1B |
| 总资产 | $433.0M | $7.0B |
| 负债/权益比越低杠杆越低 | 0.58× | — |
8季度趋势，按日历期对齐
现金及短期投资ARQTRBCAA
| Q4 25 | $42.9M | $220.0M | ||
| Q3 25 | $47.1M | $484.2M | ||
| Q2 25 | $72.7M | $484.8M | ||
| Q1 25 | $53.1M | $793.0M | ||
| Q4 24 | $71.3M | $432.2M | ||
| Q3 24 | $134.9M | $530.9M | ||
| Q2 24 | $84.3M | $400.1M | ||
| Q1 24 | $190.1M | $546.4M |
总债务ARQTRBCAA
| Q4 25 | $109.0M | — | ||
| Q3 25 | $108.5M | — | ||
| Q2 25 | $108.0M | — | ||
| Q1 25 | $107.6M | — | ||
| Q4 24 | $107.2M | — | ||
| Q3 24 | $204.6M | — | ||
| Q2 24 | $203.8M | — | ||
| Q1 24 | $202.8M | — |
股东权益ARQTRBCAA
| Q4 25 | $189.5M | $1.1B | ||
| Q3 25 | $158.1M | $1.1B | ||
| Q2 25 | $139.0M | $1.1B | ||
| Q1 25 | $142.7M | $1.0B | ||
| Q4 24 | $157.5M | $992.0M | ||
| Q3 24 | $156.6M | $979.7M | ||
| Q2 24 | $186.4M | $955.4M | ||
| Q1 24 | $224.9M | $935.6M |
总资产ARQTRBCAA
| Q4 25 | $433.0M | $7.0B | ||
| Q3 25 | $371.0M | $7.0B | ||
| Q2 25 | $352.4M | $7.0B | ||
| Q1 25 | $344.1M | $7.1B | ||
| Q4 24 | $348.9M | $6.8B | ||
| Q3 24 | $437.4M | $6.7B | ||
| Q2 24 | $444.8M | $6.6B | ||
| Q1 24 | $478.5M | $6.9B |
负债/权益比ARQTRBCAA
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 0.90× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | — | $161.1M |
| 自由现金流率自由现金流/营收 | — | 170.9% |
| 资本支出强度资本支出/营收 | 0.0% | 7.5% |
| 现金转化率经营现金流/净利润 | 1.51× | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流ARQTRBCAA
| Q4 25 | $26.2M | $168.2M | ||
| Q3 25 | $-1.8M | $33.3M | ||
| Q2 25 | $324.0K | $8.4M | ||
| Q1 25 | $-30.4M | $93.2M | ||
| Q4 24 | $-748.0K | $149.0M | ||
| Q3 24 | $-34.7M | $51.3M | ||
| Q2 24 | $-45.1M | $4.0M | ||
| Q1 24 | $-31.6M | $71.2M |
自由现金流ARQTRBCAA
| Q4 25 | — | $161.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | $246.0K | $5.2M | ||
| Q1 25 | $-31.0M | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | $-34.8M | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率ARQTRBCAA
| Q4 25 | — | 170.9% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | 0.3% | 5.5% | ||
| Q1 25 | -47.1% | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | -77.8% | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度ARQTRBCAA
| Q4 25 | 0.0% | 7.5% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.1% | 3.5% | ||
| Q1 25 | 0.9% | 1.2% | ||
| Q4 24 | 0.0% | 6.5% | ||
| Q3 24 | 0.3% | 1.7% | ||
| Q2 24 | 0.0% | 1.5% | ||
| Q1 24 | 0.0% | 1.7% |
现金转化率ARQTRBCAA
| Q4 25 | 1.51× | 7.37× | ||
| Q3 25 | -0.24× | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
